Next generation whole blood analysis

We empower researchers to develop safer medicines.

Services to help you understand human immune responses during non-clinical development.

Powered by our experienced team and unique technology, we help scientists study immune responses triggered by candidate drugs, exploring the interconnected world of immune cells, complement factors, immunoglobulins, and other systems in human blood. By working with us, you get human-based data that supports IND & IMPD submissions, helping you make informed decisions about clinical development.

The ID.Flow® technology.

-Access to donors directly at our test site enables real-time whole-blood analysis.

-ID.Flow detects human-specific immune responses that can be difficult to assess with conventional methods.

-Mimics human blood circulation and comprehensively evaluates how drugs affect cytokine release, ADCC/CDC, complement activation, cell activation, and platelets.

 

Why Immuneed?

Regulatory authorities increasingly encourage new approach methodologies (NAMs), supporting the use of non-clinical models due to their potential to reliably and efficiently produce information that is fit for purpose while reducing animal use. Immuneed’s services combine expertise with our unique ex vivo system to de-risk first-in-human studies while meeting new regulatory requirements.

Trusted by drug developers across the globe.

How we can help

CANDIDATE SELECTION

Prioritise drug candidates with a favourable safety profile.

DOSE SELECTION

Choose a safe starting dose for first-in-human studies.

WEIGHT OF EVIDENCE

Complement your preclinical package with human-based data.

ID.Flow®

Frequently asked Questions

No items available